Application 079033
- Type
- ANDA
- Sponsor
- MYLAN INSTITUTIONAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FOMEPIZOLE | FOMEPIZOLE | INJECTABLE;INJECTION | 1.5GM/1.5ML (1GM/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A079033-001 | FOMEPIZOLE | FOMEPIZOLE | 1.5GM/1.5ML (1GM/ML) | INJECTABLE / INJECTION | 2009-04-07 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A079033-001 | FOMEPIZOLE | 1.5GM/1.5ML (1GM/ML) | INJECTABLE / INJECTION | 2009-04-07 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A079033-001 | FOMEPIZOLE | 1.5GM/1.5ML (1GM/ML) | INJECTABLE / INJECTION | 2009-04-07 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A079033-001 | FOMEPIZOLE | 1.5GM/1.5ML (1GM/ML) | INJECTABLE / INJECTION | 2009-04-07 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A079033-001 | FOMEPIZOLE | 1.5GM/1.5ML (1GM/ML) | INJECTABLE / INJECTION | 2009-04-07 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fomepizole | FOMEPIZOLE | Zydus Pharmaceuticals USA Inc. | 256910fe-91f2-48f6-b0b4-55edc52dacd4 | 2025-11-20 | Adverse reactions | Fomepizole FOMEPIZOLE |
| Fomepizole | FOMEPIZOLE | Navinta LLC | 6fed6052-f159-46d6-8be1-31e18a7ba918 | 2024-12-19 | Adverse reactions | Fomepizole FOMEPIZOLE |
| Fomepizole | FOMEPIZOLE | Sagent Pharmaceuticals | 1dea37fd-ec17-416e-b28e-980a87d49e1a | 2023-10-26 | Adverse reactions | Fomepizole FOMEPIZOLE |
| Fomepizole | FOMEPIZOLE | Gland Pharma Limited | 7e133194-dacb-446a-a657-2d2430a02373 | 2023-07-07 | Adverse reactions | Fomepizole FOMEPIZOLE |
| Fomepizole | FOMEPIZOLE | Mylan Institutional LLC | 911312e2-3a7c-4c97-88a8-b8d92cd12923 | 2021-04-15 | Adverse reactions | Fomepizole FOMEPIZOLE |
| fomepizole | FOMEPIZOLE | American Regent, Inc. | a31d0148-2729-49de-b666-f24b0dfd2401 | 2020-02-11 | Adverse reactions | fomepizole FOMEPIZOLE |
| fomepizole | FOMEPIZOLE | American Regent, Inc. | 82dc2920-af7f-4e43-9f6d-8877a71884cd | 2019-12-06 | Adverse reactions | fomepizole FOMEPIZOLE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.